the economic downturn may be a godsend for sbn

The way I see it, with an inevitable slow shift to saliva testing in the workplace and elsewhere,SBN is a sure thing to succeed, assuming that their IP stays ahead of the pack. For me the biggest concern that I have had and still have about SBN is that their IP will eventually be surpassed and frankly it is inevitable that oraline 4 and oraline 8 will be superseeded with a superior saliva test. Success for SBN relies upon them being fully established and profitable before their competitors catch up. The economic downturn will almost certainly result in less money for R and D across the entire market, particularly in areas of unproven revenue streams, such as saliva testing. Therefore the competition is less likely to catch up. Basically what I'm trying to say is that the downturn will probably buy SBN a couple of extra years to become established.